Increased risk of 2-year death in patients who discontinued their use of statins.
Karla L SeamanFrank SanfilippoMax BulsaraElizabeth RougheadAnna Kemp-CaseyCaroline BulsaraGerald F WattsDavid PreenPublished in: Journal of health services research & policy (2020)
Patients who discontinued their statin therapy had a significantly increased risk of IHD and stroke death. Health professionals should be aware that large co-payment changes may be associated with patients discontinuing or reducing medicines to their health detriment. Factors that lead to such changes in patient medication-taking behaviour need to be considered and addressed at the clinical and policy levels.
Keyphrases
- healthcare
- public health
- end stage renal disease
- cardiovascular disease
- mental health
- newly diagnosed
- ejection fraction
- chronic kidney disease
- atrial fibrillation
- coronary artery disease
- prognostic factors
- peritoneal dialysis
- case report
- emergency department
- type diabetes
- patient reported outcomes
- climate change
- brain injury
- adverse drug